ALL KEYWORDS
Breast Cancer Chemoprevention
Related Specialists
Showing 3 of 27
Related Clinical Trials
Showing 2 of 5
Comparing Oral Drug Dosing Strategies in Older Patients With Metastatic Breast Cancer to Maximize Tolerance and Reduce Discontinuation: The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Breast Cancer
A Phase 1, First-in-Human Study of MEN2312, a KAT6 Inhibitor, as Monotherapy and in Combination in Participants With Advanced Breast Cancer
- Phase 1 Cancers
Related Departments
Showing 3 of 41